1028 GMT November 15, 2018
According to Science Daily, low levels of hormone-stimulated lipolysis — a biochemical process by which triglycerides are broken down into energy-rich fatty acids — were associated with weight gain and metabolic problems 13 years later.
Based on the findings, the researchers developed an algorithm to detect impairments in hormone-stimulated lipolysis using clinical and blood measures.
Senior author Mikael Ryden of Karolinska Institutet said, "Our proposed algorithm could be useful in identifying subjects with a high risk of becoming overweight or obese.
This information could be used by clinicians to determine who would benefit the most from intensified lifestyle interventions such as physical activity, which enhances hormone-stimulated lipolysis and may therefore prevent fat accumulation and metabolic disturbances."
Rydén and his team took biopsies of subcutaneous fat tissue from 89 women, all of whom were initially healthy and non-obese, and followed up 13 years later.
The women who gained weight in the interim showed a 50 percent increase in spontaneous lipolysis and a 50 percent decrease in hormone-stimulated lipolysis compared with weight-stable individuals.
Moreover, lower expression of genes involved in regulating lipolysis was associated with later weight gain.
First author Peter Arner of Karolinska Institutet said,
"The findings suggest that insufficient lipolysis, that is, high basal lipolysis which cannot be adequately accelerated by hormone stimulation, may shift the balance in lipid turnover towards uptake, which facilitates fat mass growth."
The researchers next constructed an algorithm to estimate hormone-stimulated lipolysis based on clinical and blood measures instead of tissue biopsies.
To identify parameters for this metabolic measure, they analyzed data from 1,045 subjects. The six resulting parameters included waist circumference, fasting plasma high-density lipoprotein cholesterol, fasting plasma adrenaline, body weight, fasting serum insulin, and fasting plasma glycerol divided by total body fat.
In a subset of 226 subjects, the algorithm predicted high or low lipolytic activity with greater than 80 percent sensitivity and approximately 75 percent specificity.
When tested in a separate cohort of 14 subjects, the algorithm corresponded well with measured levels of hormone-stimulated lipolysis and predicted weight changes over time.
"These preliminary results suggest that our algorithm could be used instead of tissue biopsies in a routine clinical setting to estimate hormone-stimulated lipolysis," Ryden said. "However, future studies are needed to validate the algorithm in larger groups of individuals and to determine whether the findings of this study also apply to men."